Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
This study is ongoing, but not recruiting participants.
Study NCT01321567 Information provided by Eisai Inc.
First Received on March 18, 2011. Last Updated on December 28, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Refractory Reflux Esophagitis
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Esophageal Motility Disorders
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Eisai Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers